AstraZeneca in talks over £300bn mega-merger with US rival, says FT report

Yorkshire Post Yorkshire Post

AstraZeneca has held talks with US rival Bristol Myers Squibb over a merger which could create a drugs giant worth more than £300 billion, according to reports.

Read full article at Yorkshire Post →